Board of Directors

Mrs. Søgaard served for 22 years at the Kammeradvokaten/Law Firm Poul Schmith as a corporate lawyer, partner and board member. After making partner in January of 2000, Mrs. Søgaard primarily worked with technology and processes to acquire technology solutions at the firm and ultimately served on the firm’s board of directors beginning in 2014. After leaving the firm in 2017, Mrs. Søgaard served on various boards including How to Robot, a platform company supporting the acquisition of physical robots for customers and suppliers and Altapay, a payment solution company. From 2018 to 2020, Mrs. Søgaard joined Evaxion Biotech and served as an executive, corporate lawyer and legal advisor to the company.

Steven is the former Sr V.P. R&D and Head of Infectious Disease & Vaccines at MedImmune, retired April 2018. Prior to working at MedImmune, Steve served as V.P., Global and Head of Infectious Disease at Novartis and V.P. and Head of Biological Technologies at Wyeth. Steven is an expert in infectious diseases, having worked many years with both basic and applied research, successfully led four programs resulting in the approval of novel anti-infective drugs with other in various stages of development, and produced more than 110 peer-reviewed publications.

Roberto was one of the first external investors in Evaxion. Roberto has over 20 years of pharmaceutical experience. He has been country GM and also occupied the position of Regional Leader of the Latin American Region for Teva from 2013 until 2015. He currently manages Viax Dental Technologies, an R&D venture in the Dental field. He has a B.S. of Economics from Universidad Católica Andrés Bello in Caracas, Venezuela and an MBA from Fuqua School of Business at Duke University.

Lars Holtug served for 35 years as an employee and partner of PwC in Denmark, including four years as Chairman of the Board. His clients included a number of major Danish pharmaceutical and biotech companies and he advised Boards and executives on management remuneration. He currently serves on the Boards of a number of companies, including Gaming Investment A/S and MTI Caretag Invest A/S, both of which as Chairman, and Ascendis Pharma A/S, a U.S. publicly traded company listed on the NASDAQ, as a Board member, Audit Committee Chair and member of the Remuneration Committee.

Niels received his MD from the University of Copenhagen and BA of Economics from Copenhagen Business School. He has worked as a Medical Director within the area of Companion Diagnostics and prior to that as a Medical Advisor within the area of cancer and biopharmaceuticals for AstraZeneca. Niels began this career at Servier Pharmaceuticals as Marketing Manager. Until August 2017, Niels was CEO of Evaxion, and in 2016, he was awarded “CEO of the Year” in the vaccine industry by European CEO.